Schizophrenia Treatment With Photoneuromodulation

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
Schizophrenia
Interventions
DEVICE

Photoneuromodulation

Treatments were administered daily for a period of 2 weeks (10 sessions) with a Light-Aid (Bright Photomedicine, SP, Brazil), continuous wave, 300 LED wavelength 850 nm) or with a placebo probe of the same appearance and display. The irradiation parameters created will be based on the disease, pain intensity and skin phototype. Each session has from 10 to 15 min, depending on skin phototype

Trial Locations (1)

Unknown

University of Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT05339347 - Schizophrenia Treatment With Photoneuromodulation | Biotech Hunter | Biotech Hunter